including cardiogenic shock from myocardial contusion and obstructive shock from cardiac tamponade or tension pneumothorax, which require specific diagnostic attention and management strategies.
The FDA has expanded the approval of Eli Lillys obesity medication Zepbound to include treating moderate to severe obstructive sleep apnea for people with obesity -- the first medication approved ...
A popular weight loss drug has become the first FDA-approved prescription medication to treat obstructive sleep apnea. Sleep apnea can cause a host of health problems, including the inability to ...
The U.S. Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the weight-loss drug Zepbound.The medicine, part of the class known as GLP-1 ...